The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease
- 1 July 1996
- journal article
- research article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 28 (1), 53-61
- https://doi.org/10.1016/s0272-6386(96)90130-4
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factorsKidney International, 1995
- The effect of recombinant human erythropoietin on cardiovascular responses to postural stress in dialysis patientsClinical Autonomic Research, 1993
- Changes in left ventricular size, wall thickness, and function in anemic patients treated with recombinant human erythropoietinAmerican Heart Journal, 1992
- Survival as an index of adequacy of dialysisKidney International, 1992
- Vascular changes in hemodialysis patients in response to recombinant human erythropoietinKidney International, 1989
- Echocardiographic criteria for left ventricular hypertrophy: The Framingham heart studyThe American Journal of Cardiology, 1987
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsThe American Journal of Cardiology, 1986
- Cardiovascular effects of anemiaAmerican Heart Journal, 1972
- Left Ventricular Volumes and Ejection Fraction by EchocardiographyCirculation, 1971
- The Hemodynamic Response to Chronic AnemiaCirculation, 1969